Q1 2017 : Portfolio Manager Q&A

Download PDF Version

Would you please discuss the factors that contributed to the Fund’s outperformance during the first quarter of 2017?

Large-cap growth was the best performing investment category during the first quarter. We were pleased that the Value Line Larger Companies Focused Fund delivered a quarterly return of 12.7%, more than double the S&P 500 Index and over 400 basis points above the Morningstar Large Growth Category average as of March 31, 2017.

The Fund benefited primarily from stock selection in the Information Technology and Health Care sectors. Notably, the Fund had a significant overweight to IT, and the Fund’s holdings within this sector climbed an average of 18%.

The Fund’s Health Care holdings rose 13% versus 8% for the S&P 500’s Health Care stocks. Within Health Care, the biggest contributors to Fund performance included Vertex Pharmaceuticals, which rose 48% following its announcement that a combination of its medicines successfully treated cystic fibrosis in clinical trials, and DexCom, a medical device company focused on diabetes management through its continuous glucose monitoring device, which increased 42%.

How do valuations factor into your stock selection process?

In the stock selection process, the majority of our time is spent examining the strength of each company’s business fundamentals including:
» Barriers to entry in the industry they operate
» The sustainability and rate of a company’s future growth
» Leverage in the business model
» Uniqueness of the business

Once we understand a company’s strengths and prospects, we determine an appropriate valuation factoring in what we believe is the longer term earnings growth rate. We may pay more for fast growing and unique businesses with dominant market positions, as near term valuations are typically not reflective of their future growth prospects. Conversely, if a company is not growing fast enough to support its valuation, we may pass on the investment or wait for a better entry point.

Would you discuss a recent portfolio purchase that fits your faster growth profile?

We recently added ServiceNow (NOW), a leader in IT Service Management. The company has done an excellent job servicing clients, with renewal rate percentages in the upper 90s and recently hired veteran IT leader and former CEO of eBay John Donahoe as their CEO. The sales growth outlook for the company is strong and the earning growth outlook is equally bright with expectations for earnings to increase 45% annually over the next few years.

Did the Fund participate in any merger and acquisition activity during the first quarter of 2017?

Yes, the Fund benefited when two holdings, Mobileye and Zeltiq Aesthetics, entered agreements to be acquired. Mobileye, the leading provider of software and design solutions used in camera-based Advanced Driver Assistance Systems, agreed to be acquired by Intel for $15 billion, and the company’s stock price rose 59% during the quarter. Leading pharmaceutical company, Allergan PLC, best known for its blockbuster product Botox, expanded its presence in the aesthetics market by offering to purchase Zeltiq for $2.5 billion. Zeltiq is known for its CoolSculpting System which offers non-invasive fat removal through its cooling technology. During the quarter, Zeltig’s price increased 29%.


Average Annual Returns as of 03/31/17

QTD 1 Yr 3 Yr 5 Yr 10 Yr
Investor - VALLX 12.71% 19.74% 11.10% 12.86% 7.06%
Institutional - VLLIX1 12.77% 19.90% 11.08% 12.85% 7.05%
S&P 500 Index 6.07 17.17 10.37 13.30 7.51
Morningstar Large Growth Category Avg. 8.63 14.85 8.53 11.55 7.71
Morningstar Category Rank (%) - VALLX 8 11 24 69
# of Funds in Category 1454 1306 1154 800
Morningstar Return Above Avg. Above Avg. Average
VALLX Gross / Net Expense Ratio*: 1.23% / 1.13% , VLLIX Gross / Net Expense Ratio**: 17.29% / 0.98%.
Morningstar rates funds based on enhanced Morningstar risk-adjusted returns.
Investor - VALLX Institutional - VLLIX1 S&P 500 Index Morningstar Large Growth Category Avg. Morningstar Category Rank (%) - VALLX # of Funds in Category Morningstar Return
QTD 12.71% 12.77% 6.07 8.63
1 Yr 19.74% 19.90% 17.17 14.85 8 1454
3 Yr 11.10% 11.08% 10.37 8.53 11 1306 Above Avg.
5 Yr 12.86% 12.85% 13.30 11.55 24 1154 Above Avg.
10 Yr 7.06% 7.05% 7.51 7.71 69 800 Average
VALLX Gross / Net Expense Ratio*: 1.23% / 1.13% (as of 05/01/17)
Morningstar rates funds based on enhanced Morningstar risk-adjusted returns.
Morningstar Ratings and Categories based on risk adjusted returns of Investor class shares.
1Indicates Morningstar Extended Performance. Extended performance is an estimate based on the performance of the fund’s oldest share class, adjusted for fees. The Inception Date of VLLIX is November 1, 2015.

* Effective May 1, 2015 to June 30, 2016, EULAV Securities LLC (the “Distributor”) has contractually agreed to waive a portion of the Fund’s 12b-1 fee equal to 0.10% of the Fund’s average daily net assets. This waiver can be terminated or changed before June 30, 2016 only with the approval of the Fund’s board and the Distributor. The Fund’s performance would be lower in the absence of such waivers.

There are risks associated with investing in small and mid cap stocks, which tend to be more volatile and less liquid than stocks of large companies, including the risk of price fluctuations.

The performance data quoted herein represents past performance and does not guarantee future results. Market volatility can dramatically impact the fund's short term performance. Current performance may be lower or higher than figures shown. The investment return and principal value will fluctuate so that an investor's shares, when redeemed may be worth more or less than their original cost. Past performance data through the most recent month end is available at vlfunds.com or by calling 800.243.2729.

You should carefully consider investment objectives, risks, charges and expenses of Value Line Funds before investing. This and other information can be found in the fund's prospectus and summary prospectus, which can be obtained free of charge from your investment representative, by calling 800.243.2729, or by clicking on the applicable fund at www.vlfunds.com. Please read it carefully before you invest or send money. The inception dates of Value Line Mutual Funds range from 1950 to 2016. Value Line Funds are distributed by EULAV Securities LLC. Past performance is no guarantee of future results.

Portfolio holdings are subject to change and should not be considered a recommendation to buy or sell securities. Current and future portfolio holdings are subject to risk.

The average annual returns shown above are historical and reflect changes in share price, reinvested dividends and are net of expenses. Investment results and the principal value of an investment will vary.

The Morningstar Rating™ for funds, or "star rating", is calculated for managed products (including mutual funds, variable annuity and variable life subaccounts, exchange-traded funds, closed-end funds, and separate accounts) with at least a three-year history. Exchange-traded funds and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed product's monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. The top 10% of products in each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating for a managed product is derived from a weighted average of the performance figures associated with its three-, five-, and 10-year (if applicable) Morningstar Rating metrics. The weights are: 100% three- year rating for 36-59 months of total returns, 60% five-year rating/40% three-year rating for 60-119 months of total returns, and 50% 10-year rating/30% five-year rating/20% three-year rating for 120 or more months of total returns. While the 10-year overall star rating formula seems to give the most weight to the 10-year period, the most recent three-year period actually has the greatest impact because it is included in all three rating periods. VLIFX (3 Year / 5 stars / 581 funds; 5 Year / 4 stars / 504 funds; 10 Year / 3 stars / 373 funds; ) VALLX (3 Year / 4 stars / 1284 funds; 5 Year / 3 stars / 1145 funds; 10 Year / 3 stars / 805 funds; ) VLEOX (3 Year / 4 stars / 603 funds; 5 Year / 4 stars / 533 funds; 10 Year / 4 stars / 396 funds; ) VALSX (3 Year / 3 stars / 581 funds; 5 Year / 3 stars / 504 funds; 10 Year / 4 stars / 373 funds; ) VLAAX (3 Year / 5 stars / 727 funds; 5 Year / 4 stars / 653 funds; 10 Year / 4 stars / 431 funds; ) VALIX (3 Year / 4 stars / 334 funds; 5 Year / 3 stars / 290 funds; 10 Year / 5 stars / 210 funds; ) VLDSX (3 Year / 2 stars / 245 funds; 5 Year / 1 stars / 155 funds; 10 Year / N/A stars / N/A funds; ) VAGIX (3 Year / 2 stars / 856 funds; 5 Year / 3 stars / 757 funds; 10 Year / 2 stars / 539 funds; ) VLHYX (3 Year / 1 stars / 142 funds; 5 Year / 1 stars / 132 funds; 10 Year / 2 stars / 104 funds; )